Diabetes Metab J.  2019 Oct;43(5):727-728. 10.4093/dmj.2019.0172.

Letter: Increased Serum Angiopoietin-Like 6 Ahead of Metabolic Syndrome in a Prospective Cohort Study (Diabetes Metab J 2019;43:521-9)

• Kim JH

• KMID: 2460965
• DOI: http://doi.org/10.4093/dmj.2019.0172

Abstract

No abstract available.

MeSH Terms

Cohort Studies*
Prospective Studies*

Reference

1. Stefan N, Haring HU. The role of hepatokines in metabolism. Nat Rev Endocrinol. 2013; 9:144–152.

2. Esfahani M, Baranchi M, Goodarzi MT. The implication of hepatokines in metabolic syndrome. Diabetes Metab Syndr. 2019; 13:2477–2480.

3. Meex RCR, Watt MJ. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol. 2017; 13:509–520.

4. Oike Y, Ito Y, Maekawa H, Morisada T, Kubota Y, Akao M, Urano T, Yasunaga K, Suda T. Angiopoietin-related growth factor (AGF) promotes angiogenesis. Blood. 2004; 103:3760–3765.

5. Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med. 2008; 18:6–14.

6. Oike Y, Akao M, Yasunaga K, Yamauchi T, Morisada T, Ito Y, Urano T, Kimura Y, Kubota Y, Maekawa H, Miyamoto T, Miyata K, Matsumoto S, Sakai J, Nakagata N, Takeya M, Koseki H, Ogawa Y, Kadowaki T, Suda T. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat Med. 2005; 11:400–408.

7. Ebert T, Kralisch S, Loessner U, Jessnitzer B, Stumvoll M, Fasshauer M, Tonjes A. Relationship between serum levels of angiopoietin-related growth factor and metabolic risk factors. Horm Metab Res. 2014; 46:685–690.

8. Namkung J, Koh SB, Kong ID, Choi JW, Yeh BI. Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome. Metabolism. 2011; 60:564–568.

9. Nie H, Liang Y, Wang HX, Ren HL, Wang YW, Li FD, Zheng YH. Angiopoietin-related growth factor is independently associated with lower extremity peripheral arterial disease. J Diabetes Complications. 2017; 31:433–438.

10. Namkung J, Sohn JH, Chang JS, Park SW, Kim JY, Koh SB, Kong ID, Park KS. Increased serum angiopoietin-like 6 ahead of metabolic syndrome in a prospective cohort study. Diabetes Metab J. 2019; 43:521–529.

11. Lee YB, Jun JE, Lee SE, Ahn J, Kim G, Jee JH, Bae JC, Jin SM, Kim JH. Utility of serum albumin for predicting incident metabolic syndrome according to hyperuricemia. Diabetes Metab J. 2018; 42:529–537.

12. Baek JH, Jin SM, Bae JC, Jee JH, Yu TY, Kim SK, Hur KY, Lee MK, Kim JH. Serum calcium and the risk of incident metabolic syndrome: a 4.3-year retrospective longitudinal study. Diabetes Metab J. 2017; 41:60–68.